RefleXion featured in BioWorld MedTech, October 18, 2018 issue

October 20, 2018

Reflexion looks to make splash with platform designed to turn cancer against itself

By Liz Hollis, Staff Writer

Hayward, Calif.-based Reflexion Medical, which is looking to exploit each cancer’s unique biology to destroy it, is trumpeting research to back its approach that will be presented at the American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio, taking place between Oct. 21 and 24.

“Reflexion’s presence at the ASTRO meeting is the culmination of a 10-year journey that began with a simple question: if a cancer cell emits a signal, can we shoot right back to destroy it?” asked founder and CTO, Sam Mazin. “Using biology to guide radiotherapy, we hope to have the means to turn cancer on itself.”

Mazin told BioWorld MedTech that the company is slated to have four abstracts presented at the event. “Essentially, you can think of these as our first real feasibility studies of our treatment-planning system that show our application in various areas,” Mazin explained. He noted that one of the presentations aims to demonstrate that the technology can do what current treatment approaches do with radiotherapy.

Currently, radiotherapy uses CT imaging to enable treatments in cancers involving the head and neck and prostate, which are localized – as opposed to metastatic – diseases. “We wanted to demonstrate that our system can do those types of conventional approaches,” Mazin said.

– To read the article in its entirety, click to open the PDF below.

pdf-download